UMIN ID: UMIN000000560
Registered date:01/01/2007
Phase II trial of dosetaxel and carboplatin as neoadjuvant chemotherapy in patients with stage Ib2-II nonsquamous cell carcinoma of uterine cervix
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | nonsquamous cell carcinoma of uterine cervix |
Date of first enrollment | 2006/12/01 |
Target sample size | 60 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | patients with stage Ib2 or II with diameter of over 2 cm nonsquamous cell carcinoma of uterine cervix |
Outcome(s)
Primary Outcome | Efficacy |
---|---|
Secondary Outcome | Safety |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 75years-old |
Gender | Female |
Include criteria | |
Exclude criteria | 1 fever with over 38.0C 2 infection or WBC>12,000/mm3 3 severe complications 4 neuropathy >Grade 2 5 edema > Grade 2 6 double cancer 7 pleural effusion and ascites for which drainage are necessary. 8 previous chemotherapy by taxane compounds |
Related Information
Primary Sponsor | Sankai Gynecology Study Group (SGSG) |
---|---|
Secondary Sponsor | none |
Source(s) of Monetary Support | none |
Secondary ID(s) |
Contact
public contact | |
Name | Muneaki Shimada |
Address | 36-1 Nishimachi, Yonago Japan Japan 683-8504 |
Telephone | 0859-38-6647 |
mshima12@med.tottori-u.ac.jp | |
Affiliation | Tottori University Department of Obstetrics and Gynecology |
scientific contact | |
Name | Junzo Kigawa |
Address | 32-1 Noshiro-cho, Matsue, Shimane Japan |
Telephone | 0852-60-8000 |
mshima12@med.tottori-u.ac.jp | |
Affiliation | Matsue city hospital Department of Obstetrics and Gynecology |